MIRIKIZUMAB INDUCES REDUCTION OF IL-23 RELATED CYTOKINES IL-17A AND IL-23 IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE

Schmitz, J; Higgs, R; Ho, S; Sisson, S; Tuttle, J; Pollack, P; Fischer, M; Hindryckx, P

GASTROENTEROLOGY, 2021; 160 (6): S355